ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PRITI JADAV M.D.

Internal Medicine

4,099

$540K

261
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$132
Average prescription price

Avg: $67

LINH NGUYEN MD

Internal Medicine

9,925

$1.28M

512
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 27%

$129
Average prescription price

Avg: $67

RAJBIR SANDHU MD

Internal Medicine

2,058

$264K

139
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 27%

$128
Average prescription price

Avg: $67

CHRISTY RISINGER M.D.

Internal Medicine

1,746

$222K

136
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$127
Average prescription price

Avg: $67

SHENG-KUN YAO MD

Internal Medicine

9,827

$1.24M

559
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 27%

$127
Average prescription price

Avg: $67

ALBERT MOSQUEDA MD

Internal Medicine

1,575

$199K

118
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$126
Average prescription price

Avg: $67

EBBA TSINOPOULOS MD

Internal Medicine

305

$38.3K

94
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 27%

$126
Average prescription price

Avg: $67

THUY NGUYEN MD

Internal Medicine

5,051

$633K

391
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 27%

$125
Average prescription price

Avg: $67

SYLVIA KARIAMPUZHA MD

Internal Medicine

5,451

$678K

475
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $67

CLYDE FORD M.D.

Internal Medicine

1,892

$235K

112
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $67

TERRY CHAMBLESS M.D.,P.A.

Internal Medicine

2,847

$352K

126
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $67

MARK ISAEFF M.D.

Internal Medicine

3,769

$466K

145
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $67

ALBERT GUINN MD

Internal Medicine

8,022

$991K

527
375 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$124
Average prescription price

Avg: $67

EDWARD CRAIG MD

Internal Medicine

1,738

$214K

98
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 27%

$123
Average prescription price

Avg: $67

NHU TRAN DO

Internal Medicine

4,802

$588K

188
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 27%

$123
Average prescription price

Avg: $67

CHENG CHEN MD, PH.D.

Internal Medicine

2,913

$356K

206
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$122
Average prescription price

Avg: $67

OSVALDO BAZIL-MIESES MD

Internal Medicine

2,937

$358K

564
386 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$122
Average prescription price

Avg: $67

GREGORY SKIE M.D.

Internal Medicine

1,404

$171K

69
23 are 65+

84%
patients receiving schedule two controlled substances

Avg: 1%

52%
patients receiving schedule three controlled substances

Avg: 15%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$122
Average prescription price

Avg: $67

YVETTE TOMACRUZ M.D.

Internal Medicine

6,757

$821K

435
301 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$122
Average prescription price

Avg: $67

ODETTE CAMPBELL M.D.

Internal Medicine

2,266

$274K

216
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$121
Average prescription price

Avg: $67

ZOHAIR ABBAS MD

Internal Medicine

662

$79.7K

153
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$120
Average prescription price

Avg: $67

MAXIMILIANO HERNANDEZ M.D.

Internal Medicine

16,923

$2.04M

879
728 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$120
Average prescription price

Avg: $67

DARSHAN KAPADIA M.D.

Internal Medicine

675

$81.1K

44
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 27%

$120
Average prescription price

Avg: $67

NABILA ZAIDI MD

Internal Medicine

4,665

$556K

276
170 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 27%

$119
Average prescription price

Avg: $67

DAVID HYMAN MPH

Internal Medicine

940

$111K

32
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$118
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank